A

Amgen

Makes biotech medicines for serious illnesses

Medical Value & Access Liaison

Biology & BiotechPosted on Nov 14
Full-time$157.8k - $213.5k

About the Job

Requirements

  • A doctorate degree and 2 years of Medical Affairs experience, or a master's degree and 6 years of Medical Affairs experience, or a bachelor's degree and 8 years of Medical Affairs experience.
  • Five years of biotech industry experience working directly with U.S. payer accounts is preferred.
  • Expertise in cardiovascular, metabolic, inflammation, bone, oncology, or rare disease therapeutic areas is preferred.
  • Deep knowledge of managed markets, the U.S. reimbursement landscape, pharmacoeconomics, population health, and broad healthcare trends is preferred.
  • Experience in patient access in U.S. and/or global markets is preferred.
  • Project management experience within a biopharmaceutical company is preferred.
  • Strong advocacy, communication, and team cohesion skills are preferred.
  • Critical thinking, analytical, and project management skills are preferred.
  • Ability to lead and manage projects from concept to completion is preferred.
  • Strong interpersonal, negotiation, active listening, and relationship management skills are preferred.
  • Ability to interface effectively with all levels, including senior management, is preferred.
  • Ability to influence others while fostering a value-based environment of dedication and fairness is preferred.
  • Ability to understand, plan, and navigate in a matrix and sometimes ambiguous environment is preferred.
  • Strong verbal and written communication skills and the ability to present clinical and pharmacoeconomic information clearly and effectively are preferred.
  • Creativity and foresight in anticipating and solving complex business issues are preferred.

Responsibilities

  • Represent Amgen to designated national and strategic payer accounts, providing payer and formulary support through value and medical presentations focused on therapeutic and economic outcomes and product utilization, and participating in clinical policy discussions such as evidence-based medicine, clinical guidelines, and prior authorization in areas of Amgen therapeutic expertise.
  • Identify, develop, and maintain collaborative relationships with current and future payer, employer, policy, and health economics and outcomes research opinion leaders to support Amgen’s product portfolio across therapeutic areas.
  • Interact with key internal stakeholders to provide feedback on customer trends in interpreting and using value evidence, reimbursement, and payer policy.
  • Lead national-to-regional medical and commercial alignment efforts to support consistent communication of clinical and economic evidence, address payer access challenges, and facilitate pull-through.
  • Provide complex value-based technical information, including medical education, health outcomes, pharmacoeconomics information and models, and research protocol opportunities to appropriate audiences.
  • Serve as the payer-focused clinical subject matter expert for designated products, leading the development and execution of medical value and access strategies, resources, and initiatives in collaboration with cross-functional stakeholders.
  • Represent Amgen to designated U.S. payer thought leaders in health economics and outcomes research for Amgen Health Economics and Outcomes Research and the Amgen Center for Observational Research.
  • Lead customer partnerships related to population health and real-world evidence generation initiatives.
  • Foster scientific information exchange related to reimbursement and coverage policy between the medical community and Amgen.
  • Collect and report competitive intelligence within Amgen’s competitive intelligence guidelines.
  • Manage internal relationships, budgets, and travel and entertainment within guidelines.
  • Conduct all assigned duties within Amgen compliance guidelines.

Desired Qualifications

  • Pharm.D., Ph.D., M.D., or D.O. is preferred.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs